Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma
- PMID:19847165
- PMCID: PMC2780341
- DOI: 10.1038/nature08462
Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma
Abstract
NF-kappaB transcription factors function as crucial regulators of inflammatory and immune responses as well as of cell survival. They have also been implicated in cellular transformation and tumorigenesis. However, despite extensive biochemical characterization of NF-kappaB signalling during the past twenty years, the requirement for NF-kappaB in tumour development in vivo, particularly in solid tumours, is not completely understood. Here we show that the NF-kappaB pathway is required for the development of tumours in a mouse model of lung adenocarcinoma. Concomitant loss of p53 (also known as Trp53) and expression of oncogenic Kras(G12D) resulted in NF-kappaB activation in primary mouse embryonic fibroblasts. Conversely, in lung tumour cell lines expressing Kras(G12D) and lacking p53, p53 restoration led to NF-kappaB inhibition. Furthermore, the inhibition of NF-kappaB signalling induced apoptosis in p53-null lung cancer cell lines. Inhibition of the pathway in lung tumours in vivo, from the time of tumour initiation or after tumour progression, resulted in significantly reduced tumour development. Together, these results indicate a critical function for NF-kappaB signalling in lung tumour development and, further, that this requirement depends on p53 status. These findings also provide support for the development of NF-kappaB inhibitory drugs as targeted therapies for the treatment of patients with defined mutations in Kras and p53.
Figures




Comment in
- Cancer: A tumour gene's fatal flaws.Downward J.Downward J.Nature. 2009 Nov 5;462(7269):44-5. doi: 10.1038/462044a.Nature. 2009.PMID:19890318No abstract available.
Similar articles
- Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.Yang L, Zhou Y, Li Y, Zhou J, Wu Y, Cui Y, Yang G, Hong Y.Yang L, et al.Cancer Lett. 2015 Feb 28;357(2):520-6. doi: 10.1016/j.canlet.2014.12.003. Epub 2014 Dec 8.Cancer Lett. 2015.PMID:25499080
- Response and resistance to NF-κB inhibitors in mouse models of lung adenocarcinoma.Xue W, Meylan E, Oliver TG, Feldser DM, Winslow MM, Bronson R, Jacks T.Xue W, et al.Cancer Discov. 2011 Aug;1(3):236-47. doi: 10.1158/2159-8290.CD-11-0073. Epub 2011 Jun 16.Cancer Discov. 2011.PMID:21874163Free PMC article.
- Requirement of the NF-kappaB subunit p65/RelA for K-Ras-induced lung tumorigenesis.Bassères DS, Ebbs A, Levantini E, Baldwin AS.Bassères DS, et al.Cancer Res. 2010 May 1;70(9):3537-46. doi: 10.1158/0008-5472.CAN-09-4290. Epub 2010 Apr 20.Cancer Res. 2010.PMID:20406971Free PMC article.
- Nuclear factor-κB, p53, and mitochondria: regulation of cellular metabolism and the Warburg effect.Johnson RF, Perkins ND.Johnson RF, et al.Trends Biochem Sci. 2012 Aug;37(8):317-24. doi: 10.1016/j.tibs.2012.04.002. Epub 2012 May 23.Trends Biochem Sci. 2012.PMID:22626470Review.
- P53 vs NF-κB: the role of nuclear factor-kappa B in the regulation of p53 activity and vice versa.Carrà G, Lingua MF, Maffeo B, Taulli R, Morotti A.Carrà G, et al.Cell Mol Life Sci. 2020 Nov;77(22):4449-4458. doi: 10.1007/s00018-020-03524-9. Epub 2020 Apr 22.Cell Mol Life Sci. 2020.PMID:32322927Free PMC article.Review.
Cited by
- Tissues and Tumor Microenvironment (TME) in 3D: Models to Shed Light on Immunosuppression in Cancer.Ho T, Msallam R.Ho T, et al.Cells. 2021 Apr 7;10(4):831. doi: 10.3390/cells10040831.Cells. 2021.PMID:33917037Free PMC article.Review.
- Dysregulated RasGRP1 responds to cytokine receptor input in T cell leukemogenesis.Hartzell C, Ksionda O, Lemmens E, Coakley K, Yang M, Dail M, Harvey RC, Govern C, Bakker J, Lenstra TL, Ammon K, Boeter A, Winter SS, Loh M, Shannon K, Chakraborty AK, Wabl M, Roose JP.Hartzell C, et al.Sci Signal. 2013 Mar 26;6(268):ra21. doi: 10.1126/scisignal.2003848.Sci Signal. 2013.PMID:23532335Free PMC article.
- TBK1 kinase addiction in lung cancer cells is mediated via autophagy of Tax1bp1/Ndp52 and non-canonical NF-κB signalling.Newman AC, Scholefield CL, Kemp AJ, Newman M, McIver EG, Kamal A, Wilkinson S.Newman AC, et al.PLoS One. 2012;7(11):e50672. doi: 10.1371/journal.pone.0050672. Epub 2012 Nov 29.PLoS One. 2012.PMID:23209807Free PMC article.
- RelA regulates CXCL1/CXCR2-dependent oncogene-induced senescence in murine Kras-driven pancreatic carcinogenesis.Lesina M, Wörmann SM, Morton J, Diakopoulos KN, Korneeva O, Wimmer M, Einwächter H, Sperveslage J, Demir IE, Kehl T, Saur D, Sipos B, Heikenwälder M, Steiner JM, Wang TC, Sansom OJ, Schmid RM, Algül H.Lesina M, et al.J Clin Invest. 2016 Aug 1;126(8):2919-32. doi: 10.1172/JCI86477. Epub 2016 Jul 25.J Clin Invest. 2016.PMID:27454298Free PMC article.
- Cell-selective inhibition of NF-κB signaling improves therapeutic index in a melanoma chemotherapy model.Enzler T, Sano Y, Choo MK, Cottam HB, Karin M, Tsao H, Park JM.Enzler T, et al.Cancer Discov. 2011 Nov;1(6):496-507. doi: 10.1158/2159-8290.CD-11-0143.Cancer Discov. 2011.PMID:22389871Free PMC article.
References
- Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004;18:2195–2224. - PubMed
- Greten FR, et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell. 2004;118:285–296. - PubMed
- Hanson JL, Hawke NA, Kashatus D, Baldwin AS. The nuclear factor kappaB subunits RelA/p65 and c-Rel potentiate but are not required for Ras-induced cellular transformation. Cancer Res. 2004;64:7248–7255. - PubMed
- Luedde T, et al. Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell. 2007;11:119–132. - PubMed
- Maeda S, Kamata H, Luo JL, Leffert H, Karin M. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell. 2005;121:977–990. - PubMed
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous